Eloxx Pharmaceuticals, Inc.
- Last sale
- Nov 12, 2026 · -3.45%
- Market cap
- $51.42M
- 4.04M shares
- Filings
- 1,021
FY 2025−100.0% FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
Q3 2023derivedN/M FY22 yoy
Q2 2026N/M FY25 yoy
Q2 2026+4,210.8% FY25 yoy
- $51.42M
- —
- —
- 1.3×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $6,359,000 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2014 | 2014-06-30 | $182,229 | reported | |
| FY 2013 | 2013-06-30 | $7,819 | reported | |
| FY 2012 | 2012-06-30 | $200,000 | reported | |
| FY 2010 | 2010-06-30 | $140,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2019 | $0.00 | — | $0.00 | — | 40.12M sh | +11.9% | — |
| FY2018 | $0.00 | — | $0.00 | — | 35.86M sh | +30.3% | — |
| FY2017 | $0.00 | — | $0.00 | — | 27.53M sh | +554.6% | — |
| FY2010 | — | $1.05M | $1.05M | — | — | — | — |
Biological products, except diagnostic substances
Eloxx Pharmaceuticals, Inc. is the 123rd largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
CGTXCognition Therapeutics Inc———$64.5MSGMOQSangamo Therapeutics, Inc$39.6M31.6%310.8%$58.0MCRDFCardiff Oncology, Inc.$593.0K13.2%7,732.0%$56.8MAPTNAdaptin Bio, Inc.———$55.4M
ELOXEloxx Pharmaceuticals, Inc. (this company)$0.0100.0%—$51.4M
INKTMiNK Therapeutics, Inc.———$49.8MTILInstil Bio, Inc.———$47.1MIMAImageneBio, Inc.$800.0K77.1%5,668.6%$45.0MIRLAIRulya Therapeutics Inc.———$40.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Eloxx Pharmaceuticals, Inc. · CIK 1035354 · Engraved from SEC EDGAR